Diclofenac Epolamine
TRANSDERMAL AND TOPICAL PATCHES TECHNOLOGY
Single and multilayer medicated patches are designed to act either locally or systemically, depending on the site of action of the active substance. Hydrogel and Drug-in-adhesive technologies are patent-protected.
Patient Information Leaflet:
CLICK HERE TO DOWNLOADACTIVE INGREDIENT
Diclofenac hydroxyethylpyrrolidine 180 mg.
Medicated plaster 5 – 8 – 10 – 15 pcs
HYDROGEL TECHNOLOGY
- Plaster with hydrogel – adherent layer with active substance – with high water content (gentle on the skin)
- Thanks to the carrier technology, it ensures a controlled release of active ingredients up to 12 hours
- Comfortable, easy to apply and remove and therefore normally very well tolerated
DRUG-IN ADHESIVE MATRIX TECHNOLOGY
- The particularly thin and dry adhesive layer adheres to the skin ensuring a gradual release of the drug. The active ingredient acts locally (topical patch) or is delivered into the body circulation (systemically acting transdermal patch)
- Transdermal drug delivery technology can find wide application in cardiovascular, anti-inflammatory, hormonal or pain therapies
Fill out the form
and you will be contacted